Ipamorelin

Ipamorelin Product Description — Research Use Only

Ipamorelin is a synthetic research peptide classified as a selective growth hormone secretagogue. It is commonly studied for growth hormone signaling, pituitary response, ghrelin/GHSR receptor activity, IGF-1 pathway research, recovery-related pathways, metabolic function, and body-composition markers.

Research on Ipamorelin has most commonly focused on growth hormone release, pituitary signaling, GHSR/ghrelin-receptor activity, IGF-1-related pathways, tissue-maintenance research, energy balance, and recovery-response markers. Published studies describe Ipamorelin as a selective growth hormone secretagogue that stimulates GH release through a GHRP-like receptor pathway.

Ipamorelin is commonly studied for:

• Growth hormone signaling — how the pituitary releases growth hormone

• Pituitary response — how the pituitary reacts to GH-releasing signals

• Ghrelin-receptor activity — how Ipamorelin interacts with GHSR-related pathways

• IGF-1 pathways — how GH signaling may influence IGF-1-related activity

• Recovery research — pathways connected to repair, restoration, and tissue maintenance

• Metabolic research — how energy use and fuel balance are studied

• Body-composition research — markers related to lean mass, fat mass, and energy balance

Ipamorelin is commonly studied because it acts as a growth hormone secretagogue, meaning it is researched for its ability to stimulate GH release rather than supply GH directly. In pharmacokinetic and pharmacodynamic research, Ipamorelin produced a GH-release response with a reported peak around 0.67 hours, followed by a decline in GH concentration across studied doses.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.